Quantcast

Latest Chronic kidney disease Stories

2014-07-17 16:26:45

NEW YORK, July 17, 2014 /PRNewswire/ -- La Jolla Pharmaceutical Company (NASDAQ: LJPC) is a biopharmaceutical company focused on the development of therapeutic agents that inhibit the activity of galectins as a means of treating human diseases such as chronic organ failure and cancer. The company's main product candidates include GCS-100 for the treatment of chronic kidney disease (CKD), LJPC-501 that is designed to help restore kidney function in patients with hepatorenal syndrome...

2014-07-16 12:27:25

NxStage Patient Advocates to travel the East Coast to share the benefits of home hemodialysis LAWRENCE, Mass., July 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today the launch of the NxStage Freedom Tour, a two week road trip in a recreational vehicle to promote and educate dialysis patients on the benefits of home hemodialysis with the NxStage System One(TM). Traveling in the NxStage Freedom...

2014-07-11 12:24:47

BUFFALO, N.Y., July 11, 2014 /PRNewswire/ -- CTG (NASDAQ:CTG) today announced that Laura Argauer, software engineer at CTG and John Gillespie M.D., M.B.A., Chief Medical Officer at Palladian Health and Clinical Associate Professor, State University of New York at Buffalo School of Medicine and Biomedical Sciences will co-present on the topic "Using Transformational Data Analytics to Improve Care Valuation, Management and Outcomes of Chronic Kidney Disease Patients" at the third...

2014-07-10 12:28:45

Interest in GCS-100, Velcalcetide, ST-10, GSK-1278863A and Rayaldee Ranges from Moderate to High, According to Findings from Decision Resources Group BURLINGTON, Mass., July 10, 2014 /PRNewswire/ -- Decision Resources Group finds that over half of surveyed nephrologists report awareness of the U.S. Food and Drug Administration's (FDA) approval of Vifor Fresenius Medical Care Renal Pharma's new phosphate binder Velphoro, which was approved by the FDA in November 2013 for the treatment of...

2014-07-10 04:21:24

STOCKHOLM, July 10, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, has had core patents for its late-stage clinical candidate Nefecon(R) issued in the key markets United States, Europe, China and Hong Kong. A patent is pending in Japan. Nefecon is a potential disease-modifying treatment for patients with primary IgA nephropathy at risk of developing end-stage renal disease. Nefecon has shown positive results in an...

2014-07-09 08:27:28

World-class Nephrologist to Lead Home Dialysis Program DENVER, July 9, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company has named Martin Schreiber, M.D., as its new vice president of clinical affairs for home modalities. http://photos.prnewswire.com/prnvar/20140303/LA75036LOGO-b DaVita's home hemodialysis (HHD) and peritoneal dialysis (PD)...

2014-07-07 16:24:14

NEW YORK, July 7, 2014 /PRNewswire/ -- Mariel Therapeutics, Inc. today announced that it has entered into a definitive agreement to acquire Stryker Corporation's (NYSE: SYK) Bone Morphogenetic Protein-7 (BMP-7) assets for the potential treatment of osteoarthritis (OA), chronic kidney disease (CKD) and other organ fibrosis conditions, lupus, and obesity. Under the terms of the agreement, Mariel acquired the rights to over 450 issued and pending patents, Stryker's BMP-7-related clinical...

2014-07-03 12:25:51

NxStage Patients embrace the flexibility of home hemodialysis to reclaim their lifestyles and live freely LAWRENCE, Mass., July 3, 2014 /PRNewswire/ -- In honor of Independence Day, NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, joins patients across the nation in celebrating the freedom and flexibility they have reclaimed with home hemodialysis (HHD) using the NxStage® System One(TM)....

2014-07-03 11:16:59

NIH/National Institute of Diabetes and Digestive and Kidney Diseases NIH study suggests people with either should be monitored for both Acute kidney injury (AKI) and chronic kidney disease (CKD) are closely intertwined, with each disease a risk factor for developing the other and sharing other risk factors in common, as well as sharing causes for the diseases to get worse, and outcomes, suggests a comprehensive analysis by scientists at the National Institutes of Health and George...

2014-07-01 16:26:22

After Review of Three Renal Anemia Product Profiles in Development, Expected Use Increases with Disease Severity, According to Findings from Decision Resources Group BURLINGTON, Mass., July 1, 2014 /PRNewswire/ -- Decision Resources Group finds that patient chart data submitted by surveyed nephrologists in China reveals that, consistent with 2011, the percentage of patients on erythropoiesis-stimulating agents (ESAs) significantly increases as chronic kidney disease (CKD) worsens; however,...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related